Table 6.
Sig. | HR(Exp B) | 95.0% CI for Exp (B) | ||
---|---|---|---|---|
Lower | Upper | |||
Donor´s age | 0.043 | 1.027 | 1.001 | 1.054 |
Recipient´s age | 0.258 | 0.983 | 0.954 | 1.013 |
reIgAN | 0.023 | 2.426 | 1.129 | 5.216 |
ABMR | 0.000 | 5.503 | 2.359 | 12.837 |
EU till 1 year after Tx | 0.008 | 3.119 | 1.341 | 7.251 |
PU till 1 year after Tx | 0.049 | 2.791 | 1.003 | 7.767 |
reIgAN, the recurrence of IgAN histological verified; ABMR, antibody mediated rejection; EU, microscopic hematuria till 1 year after kidney transplant; PU, proteinuria till 1 year after kidney transplant.
Graft survival in patients with original diagnose of IgAN was influenced by histological verified ABMR (HR = 5.5, p < 0.0001), recurrence of IgAN (HR = 2.4, p = 0.023), the onset of erythrocyturia till 1 year after kidney transplant (HR = 3.1, p = 0.008), the onset of proteinuria till 1 year after kidney transplant (HR=2.8, p=0.049), and higher age of donor (HR = 1.03, p = 0.043).